Leukaemic cutaneous T-cell lymphoma manifesting papuloerythroderma with CD3- CD4+ phenotype

Acta Dermato-Venereologica

Volumn 90, Issue 1, 2010, Pages 68-72

  Shimauchi, Takatoshi ^a   Sugita, Kazunari ^a   Nakamura, Motonobu ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cutaneous T cell lymphoma; Papuloerythroderma; Phenotype

Indexed keywords

ANTIBIOTIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; ETOPOSIDE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; ERYTHRODERMA; FLOW CYTOMETRY; GRANULOMATOSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH FOLLICLE; LYMPHOCYTIC INFILTRATION; MALE; PALMOPLANTAR KERATODERMA; PAPULOERYTHRODERMA; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN DEFECT; SKIN NODULE; T CELL LEUKEMIA;

AGED; ANTIGENS, CD3; ANTIGENS, CD4; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CONCANAVALIN A; DERMATITIS, EXFOLIATIVE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MITOGENS; NEOPLASTIC CELLS, CIRCULATING; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CCR4; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 76349093148     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0786     Document Type: Article

References (20)

1. Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the Internationa Society for Cutaneous lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 1713-1722.
2. Tokura Y, Yagi H, Seo N, Takagi T, Takigawa M. Nonerythrodermic leukemic variant of cutaneous T-cell lymphoma with indolent cinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8+ T cells. J Am Acad Dermatol 2000; 43: 946-954.
3. Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, et al. Circulating clonal CLA+ and CD4+ T cells in Sézary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 2005; 152: 258-264.
4. Nazzari G, Sabatini C. Ofuji's papuloerythroderma: an association with early gastric cancer. Eur J Dermatol 1999; 9: 317-318.
5. Schepers C, Malvehy J, Azon-Masoliver A, Navarra E, Ferrando J, Mascaro JM. Papuloerythroderma of Ofuji: a report of 2 cases including the first European case associated with visceral carcinoma. Dermatology 1996; 193: 131-135.
6. Sugita K, Koga C, Yoshiki R, Izu K, Tokura Y. Papuloerythroderma caused by aspirin. Arch Dermatol 2006; 142: 792-793.
7. Shimauchi T, Ohshima A, Tokura Y. Folliculotropic mycosis fungoides presenting as papuloerythroderma. J Dermatol 2006; 33: 498-500.
8. Nashan D, Faulhaber D, Ständer S, Luger TA, Stadler R. Mycosis fungoides: a dermatological masquerader. Br J Dermatol 2007; 156: 1-10.
9. Martínez-Barranca ML, Muñoz-Pérez MA, García-Morales I, Fernández-Crehuet JL, Segura J, Camacho F. Ofuji papuloerythroderma evolving to cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol 2005; 19: 104-116.
10. Ofuji S, Furukawa F, Miyachi Y, Ohno S. Papuloerythroderma. Dermatologica 1984; 169: 125-130.
11. Sugita K, Kabashima K, Nakashima D, Tokura Y. Papuloerythroderma of Ofuji induced by furosemid. J Am Acad Dermatol 2008; 58: 54-55.
12. Vowels BR, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe JT, et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994; 103: 669-673.
13. Seo N, Tokura Y, Matsumoto K, Furukawa F, Takigawa M. Tumor-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-g (IFN-γ) and IL-12 and fluctuations in association with disease activity. Clin Exp Immunol 1998; 112: 403-409.
14. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997; 272: 15036-15047.
15. Imai T, Chantry D, Raport CJ, Woods CL, Nishimura M, Godiska R, et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998; 273: 1764-1768.
16. Lee BN, Duvic M, Tang CK, Bueso-Ramos C, Estrov Z, Reuben JM. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol 1999; 6: 79-84.
17. Fischer MB, Hauber I, Fodinger M, Wolf HM, Thon V, Donath P, et al. Defective TCR surface expression associated with impaired TCR beta-chain assembly in a patient with cutaneous T-cell lymphoma. J Invest Dermatol 1995; 104: 537-550.
18. Tokura Y, Heald PW, Yan SL, Edelson RL. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. J Invest Dermatol 1992; 98: 33-37.
19. Sano S, Matsui Y, Itami S, Yoshikawa K. Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome. Clin Exp Immunol 1998; 113: 190-197.
20. Heald PW, Yan SL, Edelson RL, Tigelaar R, Picker FJ. Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 1993; 101: 222-226.